Viking Thera (VKTX)

$50.90 0.80 (1.60%)

16:00 EDT VKTX Stock Quote Delayed 30 Minutes

3 Undervalued Biotech Stocks With Breakout Potential

By Muslim Farooque, InvestorPlace Contributor Jul 19, 2024

Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements

3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition

The 3 Most Undervalued Biotech Stocks to Buy in July 2024

3 Overlooked Giants-in-the-Making for Patient Investors

Volume:

Previous Close -

Market Cap 5.07B

PE Ratio -54.73

EPS -0.93

Volume (Avg. Vol.) 1.89M

Day's Range $49.75 - $52.34

52-Week Range $8.28 - $99.41

Dividend & Yield N/A (N/A)

VKTX Stock Predictions, Articles, and Viking Thera News

3 Biotech Moonshots With Imminent Catalyst Potential

By Ian Cooper, InvestorPlace Contributor Jul 3, 2024

Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.

The 3 Smartest Biotech Stocks to Buy With $5K Right Now

By Ian Cooper, InvestorPlace Contributor Jun 28, 2024

With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs.

The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains

By Joel Baglole, InvestorPlace Contributor Jun 28, 2024

Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector.

3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years

By Ian Cooper, InvestorPlace Contributor Jun 13, 2024

One of the best ways to spot winning stocks to buy is by spotting hot trends, such as artificial intelligence and obesity.

Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm

By Rich Duprey, InvestorPlace Contributor Jun 8, 2024

You can use the wisdom of crowds and their fear and greed motives to profit from these three stocks to buy with plenty of room to run.

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names

By Chandler Capital, InvestorPlace Contributor May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

3 Biotech Stocks That Could Be Millionaire-Makers: May Edition

By Mohammed Saqib, InvestorPlace Contributor May 25, 2024

Investors should take a close look at these biotech stocks as they position themselves to provide high returns.

Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound

By Rick Orford, InvestorPlace Contributor May 23, 2024

Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention.

3 Growth Stocks That Could Be Millionaire-Makers: May Edition

By Joel Baglole, InvestorPlace Contributor May 21, 2024

Investors wanting to get rich should consider a long-term holding in these stocks, each of which has risen exponentially in the last year.

Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024

By Joel Baglole, InvestorPlace Contributor May 20, 2024

Consider following the recommendations of analysts and buy these small but mighty companies whose stocks are rising.

Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?

By Alex Sirois, InvestorPlace Contributor May 17, 2024

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.

Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000

By Stavros Tousios, InvestorPlace Contributor May 16, 2024

Top small-cap stocks to buy Viking Therapeutics, Celsius and Hippo make waves in the weight loss, energy drink, and insurance tech sectors.

The 3 Best Russell 2000 Stocks to Buy in May 2024

By Michael Que, InvestorPlace Contributor May 10, 2024

If you are looking for investments that will deliver high returns, these are the best Russell 2000 stocks to buy for your portfolio.

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025

By Alex Sirois, InvestorPlace Contributor May 9, 2024

The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

By Josh Enomoto, InvestorPlace Contributor May 7, 2024

Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because…

What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks

By Larry Ramer, InvestorPlace Contributor May 2, 2024

Data indicates that many more Americans have become aware of the dangers of obesity. Here are the best weight loss stocks to buy now.

Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge

By Viktor Zarev, InvestorPlace Contributor May 1, 2024

A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.

3 Biotech Stocks to Buy on the Dip: April 2024

By Josh Enomoto, InvestorPlace Contributor Apr 26, 2024

If you follow Warren Buffett’s advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on…

VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024

By InvestorPlace Earnings Apr 24, 2024

VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

3 Biotech Stocks With Skyrocketing Potential: April 2024

By Muslim Farooque, InvestorPlace Contributor Apr 24, 2024

These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.

Viking Thera (VKTX)

3 Undervalued Biotech Stocks With Breakout Potential

3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition

The 3 Most Undervalued Biotech Stocks to Buy in July 2024

3 Overlooked Giants-in-the-Making for Patient Investors

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Viking Thera (VKTX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VKTX Stock Predictions, Articles, and Viking Thera News

Subscriber Sign in